Core Insights - Beijing Yiqiao Shenzhou Technology Co., Ltd. has been awarded the "2025 Supplier Performance Recognition Award" by Scientist.com for its outstanding contributions and performance in advancing global drug discovery research [1][3]. Company Overview - Yiqiao Shenzhou is an international reagent supplier and contract research service provider, focusing on recombinant protein production and antibody development. The company operates under a strict quality management system, offering unique biological reagents for fields such as cell therapy, stem cell research, and infectious disease research [5]. Performance Metrics - The Supplier Performance Recognition Award is given to partners that excel in key performance indicators such as responsiveness, marketplace activity, and customer satisfaction. Yiqiao Shenzhou achieved a responsiveness rate of 90%, contributing significantly to global research efficiency [3][4]. Service Offerings - In 2025, Yiqiao Shenzhou provided critical technical services through the Scientist.com platform, covering areas such as protein biology, antibody development, in vitro testing, in vitro pharmacology, and innovative drug CMC [4]. - The company offers a one-stop service from gene synthesis to protein expression and purification using four major systems: mammalian cells, baculovirus-insect cells, E. coli, and cell-free expression systems [4]. Collaboration and Recognition - Yiqiao Shenzhou has developed over 30,000 antibodies and established strong partnerships with many international pharmaceutical companies, highlighting its leading position in the global life sciences research and drug development sector [4][5]. - The Chief Business Officer of Yiqiao Shenzhou expressed pride in the recognition from Scientist.com and emphasized the company's commitment to providing reliable, timely, and innovative solutions for the global scientific community [5]. Industry Context - Scientist.com is a leading AI-driven procurement platform in the life sciences sector, connecting researchers with a global network of over 6,000 suppliers to accelerate scientific discovery [6].

Core Viewpoint - Yiqiao Shenzhou announced on September 4 that its subsidiaries in Taizhou and Suzhou are progressing steadily in their respective businesses, with Taizhou's reagent and service operations experiencing relatively rapid growth, while Suzhou's biological safety testing services face longer market expansion cycles due to certification and client example requirements [1] Group 1 - The Taizhou subsidiary is engaged in reagent and service business, which does not require certification and is growing relatively quickly [1] - The Suzhou subsidiary primarily provides biological safety testing services, which require certification and client examples, leading to a longer market expansion cycle [1] - Overall, both subsidiaries are progressing according to plan and have shown a stable growth trend [1]